Intensity Therapeutics Inc (INTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,434 | -11,606 | -8,555 | -5,884 | -3,347 |
| Depreciation Amortization | 7 | 26 | 19 | 13 | 6 |
| Accounts payable and accrued liabilities | 87 | 360 | 498 | 394 | 866 |
| Other Working Capital | 214 | 347 | 154 | 347 | 917 |
| Other Operating Activity | 300 | 1,640 | 1,052 | 685 | -431 |
| Operating Cash Flow | $-1,826 | $-9,233 | $-6,832 | $-4,445 | $-1,989 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 157 | 19,447 | 12,560 | 4,088 | 345 |
| Other Financing Activity | -7 | -883 | -1,251 | -17 | -17 |
| Financing Cash Flow | $150 | $18,564 | $11,309 | $4,071 | $328 |
| Beginning Cash Position | 11,921 | 2,590 | 2,590 | 2,590 | 2,590 |
| End Cash Position | 10,245 | 11,921 | 7,067 | 2,216 | 929 |
| Net Cash Flow | $-1,676 | $9,331 | $4,477 | $-374 | $-1,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,826 | -9,233 | -6,832 | -4,445 | -1,989 |
| Free Cash Flow | -1,826 | -9,233 | -6,832 | -4,445 | -1,989 |